EarningsQ2 2025 Earnings Report

Amphastar Pharmaceuticals (29A) Q2 2025 Earnings Report

2 Followers

DE:29A Q2 2025 EPS Results

Actual EPS€0.76

Consensus EPS€0.66

Beat/MissBeat by +€0.10

One Year Ago EPS€0.84

Actual Revenue€156.15M

Expected Revenue€155.77M

Beat/MissBeat by +€385.88K

YoY Revenue Growth-4.38%

QuarterQ2 2025

Date08/07/2025

TimeAfter Close

Conference CallThursday, August 7, 2025

DE:29A Upcoming Earnings

Amphastar Pharmaceuticals's next earnings date is estimated for November 9, 2026, based on past reporting schedules.

DE:29A Q2 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 09, 2026	2026 (Q3)	0.77 / -	0.833	―
Aug 06, 2026	2026 (Q2)	0.56 / 0.81	0.761	7.06% (+0.05)
May 07, 2026	2026 (Q1)	0.63 / 0.38	0.663	-43.24% (-0.29)
Feb 26, 2026	2025 (Q4)	0.81 / 0.65	0.824	-20.65% (-0.17)
Nov 06, 2025	2025 (Q3)	0.74 / 0.83	0.859	-3.12% (-0.03)
Aug 07, 2025	2025 (Q2)	0.66 / 0.76	0.842	-9.57% (-0.08)
May 07, 2025	2025 (Q1)	0.62 / 0.66	0.931	-28.85% (-0.27)
Feb 27, 2025	2024 (Q4)	0.84 / 0.82	0.788	4.55% (+0.04)
Nov 06, 2024	2024 (Q3)	0.88 / 0.86	1.03	-16.52% (-0.17)
Aug 07, 2024	2024 (Q2)	0.69 / 0.84	0.582	44.62% (+0.26)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed